Paniz Mojdeganlou
Overview
Explore the profile of Paniz Mojdeganlou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
SeyedAlinaghi S, Karimi A, Afsahi A, Mirzapour P, Varshochi S, Mojdeganlou H, et al.
Infect Disord Drug Targets
. 2023 Jun;
PMID: 37259934
Introduction: Since the beginning of the COVID-19 pandemic, face masks have been among the cornerstones of COVID-19 prevention. Therefore, evaluating their preventive effects against COVID-19 is crucial. This review aimed...
2.
SeyedAlinaghi S, Bagheri A, Razi A, Mojdeganlou P, Mojdeganlou H, Afsahi A, et al.
Arch Acad Emerg Med
. 2023 May;
11(1):e28.
PMID: 37215236
Introduction: Several clinical manifestations have been discovered for COVID-19 since the emergence of SARS-CoV-2, which can be classified into early, medium, and long-term complications. However, late complications can be present...
3.
SeyedAlinaghi S, Afsahi A, Shahidi R, Kianzad S, Pashaei Z, Mirahmad M, et al.
J Smok Cessat
. 2023 May;
2023:7656135.
PMID: 37214631
Introduction: Smoking status appears to lead to a poor prognosis in COVID-19 patients. However, findings from the studies conducted on this topic have not been consistent, and further exploration is...
4.
SeyedAlinaghi S, Karimi A, Mirzapour P, Salmani R, Razi A, Mojdeganlou H, et al.
Infect Disord Drug Targets
. 2023 May;
23(7):29-38.
PMID: 37138433
Introduction: Earlier reports described the possibility of higher SARS-CoV-2 infection and severity in patients with hematological malignancies. Given the importance and incidence of these malignancies, we aimed to systematically review...
5.
SeyedAlinaghi S, Afzalian A, Pashaei Z, Varshochi S, Karimi A, Mojdeganlou H, et al.
Health Sci Rep
. 2023 Feb;
6(2):e1080.
PMID: 36721396
Background And Aims: Alteration in humans' gut microbiota was reported in patients infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The gut and upper respiratory tract (URT) microbiota harbor a...
6.
SeyedAlinaghi S, MohsseniPour M, Saeidi S, Habibi P, Dashti M, Nazarian N, et al.
Arch Acad Emerg Med
. 2022 Nov;
10(1):e76.
PMID: 36426163
Introduction: Rare serious complications have been documented after COVID-19 vaccination as clinical research proceeded and new target populations, such as children and pregnant women, were included. In this study, we...
7.
Dadras O, SeyedAlinaghi S, Karimi A, Shojaei A, Amiri A, Mahdiabadi S, et al.
Arch Acad Emerg Med
. 2022 Aug;
10(1):e53.
PMID: 36033989
Introduction: Controversies existed regarding the duration of COVID-19 vaccines' protection and whether receiving the usual vaccine doses would be sufficient for long-term immunity. Therefore, we aimed to systematically review the...